Skip to main content
SpringerLink
Log in

Pathogenesis and prognosis of thrombotic microangiopathy

  • REVIEW ARTICLE
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Thrombotic microangiopathy (TMA) is a clinicopathological syndrome characterized by thrombosis formation in the microvasculature of various organs. Included in the broad category of TMA are the hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Typical HUS is caused by Escherichia coli O157:H7, which produces the Shiga-like toxins; Stx-1 and Stx-2. In addition to damaging endothelial cells via the inhibition of protein synthesis, Shiga-like toxins also activate endothelial cells to produce inflammatory mediators, amplifying the prothrombogenic state. Although most patients with typical HUS recover renal functions, recent analysis has shown that typical HUS is not a benign disease in the long term. Genetic abnormalities of complement regulatory proteins predispose patients to atypical HUS. Mutations in factor H, membrane cofactor protein, and factor I are known to be associated with atypical HUS. Atypical HUS forms have a poor outcome and show recurrent and progressive courses. Autoimmune IgG inhibitors of a disintegrin and metalloprotease, with thrombospodin-1-like domains (ADAMTS) 13 and mutations of the ADAMTS13 gene lead to the development of TTP. Without treatment, TTP is associated with a very high mortality rate. As it is for atypical HUS, plasma exchange is currently the most feasible treatment for TTP. Etiological diagnosis at the bedside and the development of disease-specific therapeutic modalities will enable us to optimize the management of patients with TMA and improve their prognosis in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. P Ruggenenti M Noris G Remuzzi (2001) ArticleTitleThrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura Kidney Int 60 831–46 Occurrence Handle1:CAS:528:DC%2BD3MXmvFKjtrY%3D Occurrence Handle10.1046/j.1523-1755.2001.060003831.x Occurrence Handle11532079

    Article  CAS  PubMed  Google Scholar 

  2. HM Tsai (2003) ArticleTitleAdvances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura J Am Soc Nephrol 14 1072–81 Occurrence Handle10.1097/01.ASN.0000060805.04118.4C Occurrence Handle12660343

    Article  PubMed  Google Scholar 

  3. JL Moake (2002) ArticleTitleThrombotic microangiopathies N Engl J Med 347 589–600 Occurrence Handle1:CAS:528:DC%2BD38Xmt1yit7Y%3D Occurrence Handle10.1056/NEJMra020528 Occurrence Handle12192020

    Article  CAS  PubMed  Google Scholar 

  4. N Besbas D Karpman D Landau C Loirat W Proesmans G Remuzzi et al. (2006) ArticleTitleEuropean Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders Kidney Int 70 423–31 Occurrence Handle1:STN:280:DC%2BD28vkslejtg%3D%3D Occurrence Handle10.1038/sj.ki.5001581 Occurrence Handle16775594

    Article  CAS  PubMed  Google Scholar 

  5. PI Tarr CA Gordon WL Chandler (2005) ArticleTitleShiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome Lancet 365 1073–86 Occurrence Handle1:CAS:528:DC%2BD2MXisFGrs7Y%3D Occurrence Handle15781103

    CAS  PubMed  Google Scholar 

  6. M Nangaku SJ Shankland WG Couser RJ Johnson (1998) ArticleTitleA new model of renal microvascular injury Curr Opin Nephrol Hypertens 7 457–62 Occurrence Handle1:STN:280:DyaK1czlsVGjsw%3D%3D Occurrence Handle10.1097/00041552-199807000-00018 Occurrence Handle9690047

    Article  CAS  PubMed  Google Scholar 

  7. LW Riley RS Remis SD Helgerson HB McGee JG Wells BR Davis et al. (1983) ArticleTitleHemorrhagic colitis associated with a rare Escherichia coli serotype N Engl J Med 308 681–5 Occurrence Handle1:STN:280:DyaL3s7ktFKrsg%3D%3D Occurrence Handle10.1056/NEJM198303243081203 Occurrence Handle6338386

    Article  CAS  PubMed  Google Scholar 

  8. BP Bell M Goldoft PM Griffin MA Davis DC Gordon PI Tarr et al. (1994) ArticleTitleA multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience JAMA 272 1349–53 Occurrence Handle1:STN:280:DyaK2M%2FhvV2kuw%3D%3D Occurrence Handle10.1001/jama.1994.03520170059036 Occurrence Handle7933395

    Article  CAS  PubMed  Google Scholar 

  9. I Tsuboi H Ida E Yoshikawa S Hiyoshi E Yamaji I Nakayama et al. (1998) ArticleTitleAntibiotic susceptibility of enterohemorrhagic Escherichia coli O157:H7 isolated from an outbreak in Japan in 1996 Antimicrobiol Agents Chemother 42 431–2 Occurrence Handle1:CAS:528:DyaK1cXnsFKitQ%3D%3D

    CAS  Google Scholar 

  10. ME Fraser MM Chernaia YV Kozlov MN James (1994) ArticleTitleCrystal structure of the holotoxin from Shigella dysenteriae at 2.5: a resolution Nat Struct Biol 1 59–64 Occurrence Handle1:CAS:528:DyaK2cXkt1yqs7w%3D Occurrence Handle10.1038/nsb0194-59 Occurrence Handle7656009

    Article  CAS  PubMed  Google Scholar 

  11. B Boyd C Lingwood (1989) ArticleTitleVerotoxin receptor glycolipid in human renal tissue Nephron 51 207–10 Occurrence Handle1:STN:280:DyaL1M7islOjtQ%3D%3D Occurrence Handle10.1159/000185286 Occurrence Handle2644572

    Article  CAS  PubMed  Google Scholar 

  12. LA Robinson RM Hurley C Lingwood DG Matsell (1995) ArticleTitleEscherichia coli verotoxin binding to human paediatric glomerular mesangial cells Pediatr Nephrol 9 700–4 Occurrence Handle1:STN:280:DyaK28zhvFWjug%3D%3D Occurrence Handle10.1007/BF00868715 Occurrence Handle8747108

    Article  CAS  PubMed  Google Scholar 

  13. CA Lingwood (1994) ArticleTitleVerotoxin-binding in human renal sections Nephron 66 21–8 Occurrence Handle1:STN:280:DyaK2c7ltVOqtw%3D%3D Occurrence Handle10.1159/000187761 Occurrence Handle8107950

    Article  CAS  PubMed  Google Scholar 

  14. T Takeda S Dohi T Igarashi T Yamanaka K Yoshiya N Kobayashi (1993) ArticleTitleImpairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome J Infect 27 339–41 Occurrence Handle1:STN:280:DyaK2c7ktFamug%3D%3D Occurrence Handle10.1016/0163-4453(93)92474-B Occurrence Handle8308331

    Article  CAS  PubMed  Google Scholar 

  15. IM Pruimboom-Brees TW Morgan MR Ackermann ED Nystrom JE Samuel NA Cornick HW Moon (2000) ArticleTitleCattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins Proc Natl Acad Sci USA 97 10325–9 Occurrence Handle1:CAS:528:DC%2BD3cXms1Crs70%3D Occurrence Handle10.1073/pnas.190329997 Occurrence Handle10973498 Occurrence Handle27023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. TG Obrig TP Moran JE Brown (1987) ArticleTitleThe mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis Biochem J 244 287–94 Occurrence Handle1:CAS:528:DyaL2sXktF2iu7s%3D Occurrence Handle10.1042/bj2440287 Occurrence Handle3663122 Occurrence Handle1147989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. C Zoja S Angioletti R Donadelli C Zanchi S Tomasoni E Binda et al. (2002) ArticleTitleShiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-B dependent up-regulation of IL-8 and MCP-1 Kidney Int 62 846–56 Occurrence Handle1:CAS:528:DC%2BD38XntFSrsrw%3D Occurrence Handle10.1046/j.1523-1755.2002.00503.x Occurrence Handle12164866

    Article  CAS  PubMed  Google Scholar 

  18. A Matussek J Lauber A Bergau W Hansen M Rohde KE Dittmar et al. (2003) ArticleTitleMolecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells Blood 102 1323–32 Occurrence Handle1:CAS:528:DC%2BD3sXmsFWktr0%3D Occurrence Handle10.1182/blood-2002-10-3301 Occurrence Handle12702508

    Article  CAS  PubMed  Google Scholar 

  19. E Nestoridi O Tsukurov RI Kushak JR Ingelfinger EF Grabowski (2005) ArticleTitleShiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome J Thromb Haemost 3 752–62 Occurrence Handle1:STN:280:DC%2BD2M3gvFalsg%3D%3D Occurrence Handle10.1111/j.1538-7836.2005.01205.x Occurrence Handle15842359

    Article  CAS  PubMed  Google Scholar 

  20. E Nestoridi RI Kushak D Duguerre EF Grabowski JR Ingelfinger (2005) ArticleTitleUp-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin Kidney Int 67 2254–66 Occurrence Handle10.1111/j.1523-1755.2005.00329.x Occurrence Handle15882267

    Article  PubMed  Google Scholar 

  21. SA Ghosh RK Polanowska-Grabowska J Fujii T Obrig AR Gear (2004) ArticleTitleShiga toxin binds to activated platelets J Thromb Haemost 2 499–506 Occurrence Handle1:CAS:528:DC%2BD2cXktVGmsL0%3D Occurrence Handle10.1111/j.1538-7933.2004.00638.x Occurrence Handle15009469

    Article  CAS  PubMed  Google Scholar 

  22. C Jenkins GA Willshaw J Evans T Cheasty H Chart DJ Shaw et al. (2003) ArticleTitleSubtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom J Med Microbiol 52 941–7 Occurrence Handle1:CAS:528:DC%2BD2cXktVGmtb0%3D Occurrence Handle10.1099/jmm.0.05160-0 Occurrence Handle14532337

    Article  CAS  PubMed  Google Scholar 

  23. H Nakajima N Kiyokawa YU Katagiri T Taguchi T Suzuki T Sekino et al. (2001) ArticleTitleKinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance J Biol Chem 276 42915–22 Occurrence Handle1:CAS:528:DC%2BD3MXptlels7k%3D Occurrence Handle10.1074/jbc.M106015200 Occurrence Handle11557760

    Article  CAS  PubMed  Google Scholar 

  24. M Nangaku CE Alpers J Pippin SJ Shankland S Adler K Kurokawa et al. (1997) ArticleTitleA new model of renal microvascular endothelial injury Kidney Int 52 182–94 Occurrence Handle1:STN:280:DyaK2szlsFWltA%3D%3D Occurrence Handle10.1038/ki.1997.318 Occurrence Handle9211361

    Article  CAS  PubMed  Google Scholar 

  25. J Shao T Miyata K Yamada N Hanafusa T Wada KL Gordon et al. (2001) ArticleTitleProtective role of nitric oxide in a model of thrombotic microangiopathy in rats J Am Soc Nephrol 12 2088–97 Occurrence Handle1:CAS:528:DC%2BD3MXnsFWiur0%3D Occurrence Handle11562407

    CAS  PubMed  Google Scholar 

  26. M Nangaku K Yamada CE Gariepy T Miyata R Inagi K Kurokawa et al. (2002) ArticleTitleET(B) receptor protects the tubulointerstitium in experimental thrombotic microangiopathy Kidney Int 62 922–8 Occurrence Handle1:CAS:528:DC%2BD38XntFSrsrc%3D Occurrence Handle10.1046/j.1523-1755.2002.00519.x Occurrence Handle12164874

    Article  CAS  PubMed  Google Scholar 

  27. M Nangaku CE Alpers J Pippin SJ Shankland K Kurokawa S Adler et al. (1997) ArticleTitleRenal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9 Kidney Int 52 1570–8 Occurrence Handle1:CAS:528:DyaK2sXotVKns78%3D Occurrence Handle10.1038/ki.1997.487 Occurrence Handle9407502

    Article  CAS  PubMed  Google Scholar 

  28. J Hughes M Nangaku CE Alpers SJ Shankland WG Couser RJ Johnson (2000) ArticleTitleC5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis Am J Physiol Renal Physiol 278 F747–57 Occurrence Handle1:CAS:528:DC%2BD3cXjvFahtbs%3D Occurrence Handle10.1152/ajprenal.2000.278.5.F747 Occurrence Handle10807586

    Article  CAS  PubMed  Google Scholar 

  29. M Nangaku (1998) ArticleTitleComplement regulatory proteins in glomerular diseases Kidney Int 54 1419–28 Occurrence Handle1:CAS:528:DyaK1cXnsVeqtrY%3D Occurrence Handle10.1046/j.1523-1755.1998.00130.x Occurrence Handle9844117

    Article  CAS  PubMed  Google Scholar 

  30. M Nangaku CE Alpers J Pippin SJ Shankland K Kurokawa S Adler et al. (1998) ArticleTitleCD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats J Am Soc Nephrol 9 590–7 Occurrence Handle1:CAS:528:DyaK1cXisVCnt7g%3D Occurrence Handle9555661

    CAS  PubMed  Google Scholar 

  31. P Warwicker TH Goodship RL Donne Y Pirson A Nicholls RM Ward et al. (1998) ArticleTitleGenetic studies into inherited and sporadic hemolytic uremic syndrome Kidney Int 53 836–44 Occurrence Handle1:CAS:528:DyaK1cXisVKmsb0%3D Occurrence Handle10.1111/j.1523-1755.1998.00824.x Occurrence Handle9551389

    Article  CAS  PubMed  Google Scholar 

  32. J Caprioli P Bettinaglio PF Zipfel B Amadei E Daina S Gamba et al. (2001) ArticleTitleThe molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20 J Am Soc Nephrol 12 297–307 Occurrence Handle1:CAS:528:DC%2BD3MXhtl2msLw%3D Occurrence Handle11158219

    CAS  PubMed  Google Scholar 

  33. HP Neumann M Salzmann B Bohnert-Iwan T Mannuelian C Skerka D Lenk et al. (2003) ArticleTitleHaemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries J Med Genet 40 676–81 Occurrence Handle1:CAS:528:DC%2BD3sXot1yitLw%3D Occurrence Handle10.1136/jmg.40.9.676 Occurrence Handle12960213 Occurrence Handle1735586

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. A Richards MR Buddles RL Donne BS Kaplan E Kirk MC Venning et al. (2001) ArticleTitleFactor H mutations in hemolytic uremic syndrome cluster in exons 18–20, a domain important for host cell recognition Am J Hum Genet 68 485–90 Occurrence Handle1:CAS:528:DC%2BD3MXhtl2lsLY%3D Occurrence Handle10.1086/318203 Occurrence Handle11170896 Occurrence Handle1235281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. MA Dragon-Durey V Fremeaux-Bacchi C Loirat J Blouin P Niaudet G Deschenes et al. (2004) ArticleTitleHeterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases J Am Soc Nephrol 15 787–95 Occurrence Handle1:CAS:528:DC%2BD2cXhtlShu7w%3D Occurrence Handle10.1097/01.ASN.0000115702.28859.A7 Occurrence Handle14978182

    Article  CAS  PubMed  Google Scholar 

  36. T Manuelian J Hellwage S Meri J Caprioli M Noris S Heinen et al. (2003) ArticleTitleMutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome J Clin Invest 111 1181–90 Occurrence Handle1:CAS:528:DC%2BD3sXjtFCrs7w%3D Occurrence Handle10.1172/JCI16651 Occurrence Handle12697737 Occurrence Handle152934

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. J Caprioli M Noris S Brioschi G Pianetti F Castelletti P Bettinaglio et al. (2006) ArticleTitleInternational Registry of Recurrent and Familial HUS/TTP. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood 108 1267–79 Occurrence Handle1:CAS:528:DC%2BD28Xot1ymtbk%3D Occurrence Handle10.1182/blood-2005-10-007252 Occurrence Handle16621965 Occurrence Handle1895874

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. MK Pangburn (2002) ArticleTitleCutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome J Immunol 169 4702–6 Occurrence Handle1:CAS:528:DC%2BD38Xotl2qu7c%3D Occurrence Handle10.4049/jimmunol.169.9.4702 Occurrence Handle12391176

    Article  CAS  PubMed  Google Scholar 

  39. M Jozsi S Heinen A Hartmann CW Ostrowicz S Halbich H Richter et al. (2006) ArticleTitleFactor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions J Am Soc Nephrol 17 170–7 Occurrence Handle1:CAS:528:DC%2BD28XhtFyqu7o%3D Occurrence Handle10.1681/ASN.2005080868 Occurrence Handle16338962

    Article  CAS  PubMed  Google Scholar 

  40. J Caprioli F Castelletti S Bucchioni P Bettinaglio E Bresin G Pianetti et al. (2003) ArticleTitleComplement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease Hum Mol Genet 12 3385–95 Occurrence Handle1:CAS:528:DC%2BD3sXpsl2mtbw%3D Occurrence Handle10.1093/hmg/ddg363 Occurrence Handle14583443

    Article  CAS  PubMed  Google Scholar 

  41. M-A Dragon-Durey C Loirat S Cloarec M-A Macher J Blouin H Nivet et al. (2005) ArticleTitleAnti-factor H antibodies associated with atypical hemolytic uremic syndrome J Am Soc Nephrol 16 555–63 Occurrence Handle1:CAS:528:DC%2BD2MXhvVCkt7g%3D Occurrence Handle10.1681/ASN.2004050380 Occurrence Handle15590760

    Article  CAS  PubMed  Google Scholar 

  42. K Hogasen JH Jansen TE Mollnes J Hovdenes M Harboe (1995) ArticleTitleHereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency J Clin Invest 95 1054–61 Occurrence Handle1:STN:280:DyaK2M7ovF2quw%3D%3D Occurrence Handle10.1172/JCI117751 Occurrence Handle7883953 Occurrence Handle441440

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. MC Pickering HT Cook J Warren AE Bygrave J Moss MJ Walport M Botto (2002) ArticleTitleUncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H Nat Genet 31 424–8 Occurrence Handle1:CAS:528:DC%2BD38Xls1Orsr0%3D Occurrence Handle10.1038/ng912 Occurrence Handle12091909

    Article  CAS  PubMed  Google Scholar 

  44. C Licht S Heinen M Jozsi I Loschmann RE Saunders SJ Perkins et al. (2006) ArticleTitleDeletion of Lys224 in regulatory domain 4 of factor H reveals a novel pathomechanism for dense deposit disease (MPGN II) Kidney Int 70 42–50 Occurrence Handle1:CAS:528:DC%2BD28XmtlGlsbk%3D Occurrence Handle10.1038/sj.ki.5000269 Occurrence Handle16612335

    Article  CAS  PubMed  Google Scholar 

  45. F Vaziri-Sani L Holmberg AG Sjoholm AC Kristoffersson M Manea V Fremeaux-Bacchi et al. (2006) ArticleTitlePhenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome Kidney Int 69 981–8 Occurrence Handle1:CAS:528:DC%2BD28XitFGht7c%3D Occurrence Handle10.1038/sj.ki.5000155 Occurrence Handle16528247

    Article  CAS  PubMed  Google Scholar 

  46. M Noris S Brioschi J Caprioli M Todeschini E Bresin F Porrati et al. (2003) ArticleTitleFamilial haemolytic uraemic syndrome and an MCP mutation Lancet 362 1542–7 Occurrence Handle1:CAS:528:DC%2BD3sXovVWlsrs%3D Occurrence Handle10.1016/S0140-6736(03)14742-3 Occurrence Handle14615110

    Article  CAS  PubMed  Google Scholar 

  47. A Richards EJ Kemp MK Liszewski JA Goodship AK Lampe R Decorte et al. (2003) ArticleTitleMutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome Proc Natl Acad Sci USA 100 12966–71 Occurrence Handle1:CAS:528:DC%2BD3sXoslKmsrs%3D Occurrence Handle10.1073/pnas.2135497100 Occurrence Handle14566051 Occurrence Handle240728

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. V Fremeaux-Bacchi MA Dragon-Durey J Blouin C Vigneau D Kuypers B Boudailliez et al. (2004) ArticleTitleComplement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome J Med Genet 41 84–8 Occurrence Handle10.1136/jmg.2004.019083

    Article  Google Scholar 

  49. D Kavanagh EJ Kemp E Mayland RJ Winney JS Duffield G Warwick et al. (2005) ArticleTitleMutations in complement factor I predispose to development of atypical hemolytic uremic syndrome J Am Soc Nephrol 16 2150–5 Occurrence Handle1:CAS:528:DC%2BD2MXms1egsL4%3D Occurrence Handle10.1681/ASN.2005010103 Occurrence Handle15917334

    Article  CAS  PubMed  Google Scholar 

  50. JC Reynolds LY Agodoa CM Yuan KC Abbott (2003) ArticleTitleThrombotic microangiopathy after renal transplantation in the United States Am J Kidney Dis 42 1058–68 Occurrence Handle10.1016/j.ajkd.2003.07.008 Occurrence Handle14582050

    Article  PubMed  Google Scholar 

  51. A Zarifian S Meleg-Smith R O'Donovan RJ Tesi V Batuman (1999) ArticleTitleCyclosporine-associated thrombotic microangiopathy in renal allografts Kidney Int 55 2457–66 Occurrence Handle1:CAS:528:DyaK1MXjvFajtL4%3D Occurrence Handle10.1046/j.1523-1755.1999.00492.x Occurrence Handle10354295

    Article  CAS  PubMed  Google Scholar 

  52. P Ruggenenti (2002) ArticleTitlePost-transplant hemolytic-uremic syndrome Kidney Int 62 1093–104 Occurrence Handle10.1046/j.1523-1755.2002.00543.x Occurrence Handle12164897

    Article  PubMed  Google Scholar 

  53. F Peyvandi SM Siboni D Lambertenghi Deliliers S Lavoretano N De Fazio B Moroni et al. (2006) ArticleTitleProspective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation Br J Haematol 134 187–95 Occurrence Handle1:CAS:528:DC%2BD28Xot1ahtLg%3D Occurrence Handle10.1111/j.1365-2141.2006.06126.x Occurrence Handle16846477

    Article  CAS  PubMed  Google Scholar 

  54. H Nishi N Hanafusa Y Kondo M Nangaku Y Sugawara M Makuuchi et al. (2006) ArticleTitleClinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy Clin J Am Soc Nephrol 1 811–9 Occurrence Handle10.2215/CJN.01781105 Occurrence Handle17699291

    Article  PubMed  Google Scholar 

  55. HM Tsai (2006) ArticleTitleThe molecular biology of thrombotic microangiopathy Kidney Int 70 16–23 Occurrence Handle1:CAS:528:DC%2BD28XmtlGltL8%3D Occurrence Handle10.1038/sj.ki.5001535 Occurrence Handle16760911 Occurrence Handle2497001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. HM Tsai (2006) ArticleTitleCurrent concepts in thrombotic thrombocytopenic purpura Annu Rev Med 57 419–36 Occurrence Handle1:CAS:528:DC%2BD28Xis1Cksb8%3D Occurrence Handle10.1146/annurev.med.57.061804.084505 Occurrence Handle16409158 Occurrence Handle2426955

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. M Furlan R Robles M Galbusera G Remuzzi PA Kyrle B Brenner et al. (1998) ArticleTitlevon Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N Engl J Med 339 1578–84 Occurrence Handle1:STN:280:DyaK1M%2Fjt1Sgsg%3D%3D Occurrence Handle10.1056/NEJM199811263392202 Occurrence Handle9828245

    Article  CAS  PubMed  Google Scholar 

  58. HM Tsai EC Lian (1998) ArticleTitleAntibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura N Engl J Med 339 1585–94 Occurrence Handle1:STN:280:DyaK1M%2Fjt1Sgsw%3D%3D Occurrence Handle10.1056/NEJM199811263392203 Occurrence Handle9828246 Occurrence Handle3159001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. CL Bennett PD Weinberg K Rozenberg-Ben-Dror PR Yarnold HC Kwaan D Green (1998) ArticleTitleThrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases Ann Intern Med 128 541–4 Occurrence Handle1:STN:280:DyaK1c7nsFaktA%3D%3D Occurrence Handle10.7326/0003-4819-128-7-199804010-00004 Occurrence Handle9518398

    Article  CAS  PubMed  Google Scholar 

  60. CL Bennett CJ Davidson DW Raisch PD Weinberg RH Bennett MD Feldman (1999) ArticleTitleThrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention Arch Intern Med 159 2524–8 Occurrence Handle1:STN:280:DC%2BD3c%2FjslKltA%3D%3D Occurrence Handle10.1001/archinte.159.21.2524 Occurrence Handle10573042

    Article  CAS  PubMed  Google Scholar 

  61. HM Tsai L Rice R Sarode TW Chow JL Moake (2000) ArticleTitleAntibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura Ann Intern Med 132 794–9 Occurrence Handle1:CAS:528:DC%2BD3cXjvVChtrY%3D Occurrence Handle10.7326/0003-4819-132-10-200005160-00005 Occurrence Handle10819702 Occurrence Handle3152977

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. DG Motto AK Chauhan G Zhu J Homeister CB Lamb KC Desch et al. (2005) ArticleTitleShigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice J Clin Invest 115 2752–61 Occurrence Handle1:CAS:528:DC%2BD2MXhtVygt7nJ Occurrence Handle10.1172/JCI26007 Occurrence Handle16200209 Occurrence Handle1240119

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. M Noris G Remuzzi (2005) ArticleTitleHemolytic uremic syndrome J Am Soc Nephrol 16 1035–50 Occurrence Handle1:CAS:528:DC%2BD2MXjsVGgu7o%3D Occurrence Handle10.1681/ASN.2004100861 Occurrence Handle15728781

    Article  CAS  PubMed  Google Scholar 

  64. K Brunner MG Bianchetti TJ Neuhaus (2004) ArticleTitleRecovery of renal function after long-term dialysis in hemolytic uremic syndrome Pediatr Nephrol 19 229–31 Occurrence Handle10.1007/s00467-003-1337-4 Occurrence Handle14648326

    Article  PubMed  Google Scholar 

  65. L De Petris A Gianviti U Giordano A Calzolari AE Tozzi G Rizzoni (2004) ArticleTitleBlood pressure in the long-term follow-up of children with hemolytic uremic syndrome Pediatr Nephrol 19 1241–4 Occurrence Handle10.1007/s00467-004-1582-1 Occurrence Handle15322891

    Article  PubMed  Google Scholar 

  66. R Siegler R Oakes (2005) ArticleTitleHemolytic uremic syndrome; pathogenesis, treatment, and outcome Curr Opin Pediatr 17 200–4 Occurrence Handle10.1097/01.mop.0000152997.66070.e9 Occurrence Handle15800412

    Article  PubMed  Google Scholar 

  67. AX Garg WF Clark M Salvadori J Macnab RS Suri RB Haynes D Matsell (2005) ArticleTitleWalkerton Health Study Investigators. Microalbuminuria 3 years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination Kidney Int 67 1476–82 Occurrence Handle10.1111/j.1523-1755.2005.00225.x Occurrence Handle15780100

    Article  PubMed  Google Scholar 

  68. AX Garg WF Clark M Salvadori HR Thiessen-Philbrook D Matsell (2006) ArticleTitleAbsence of renal sequelae after childhood Escherichia coli O157:H7 gastroenteritis Kidney Int 70 807–12 Occurrence Handle1:STN:280:DC%2BD28vovFSjug%3D%3D Occurrence Handle10.1038/sj.ki.5001645 Occurrence Handle16837926

    Article  CAS  PubMed  Google Scholar 

  69. AX Garg RS Suri N Barrowman F Rehman D Matsell MP Rosas-Arellano et al. (2003) ArticleTitleLong-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression JAMA 290 1360–70 Occurrence Handle1:CAS:528:DC%2BD3sXnt1aju70%3D Occurrence Handle10.1001/jama.290.10.1360 Occurrence Handle12966129

    Article  CAS  PubMed  Google Scholar 

  70. T Igarashi J Inatomi A Wake M Takamizawa H Katayama T Iwata (1999) ArticleTitleFailure of pre-diarrheal antibiotics to prevent hemolytic uremic syndrome in serologically proven Escherichia coli O157:H7 gastrointestinal infection J Pediatr 135 768–9 Occurrence Handle1:STN:280:DC%2BD3c%2FlsVKhtg%3D%3D Occurrence Handle10.1016/S0022-3476(99)70100-9 Occurrence Handle10586184

    Article  CAS  PubMed  Google Scholar 

  71. C Wong S Jelacic R Habeeb SL Watkins PI Tarr (2000) ArticleTitleThe risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections N Engl J Med 342 1930–6 Occurrence Handle1:STN:280:DC%2BD3czit1arsg%3D%3D Occurrence Handle10.1056/NEJM200006293422601 Occurrence Handle10874060 Occurrence Handle3659814

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. GZ Panos GI Betsi ME Falagas (2006) ArticleTitleSystematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther 24 731–42 Occurrence Handle1:CAS:528:DC%2BD28XhtFGqsrvK Occurrence Handle10.1111/j.1365-2036.2006.03036.x Occurrence Handle16918877

    Article  CAS  PubMed  Google Scholar 

  73. DP Basile D Donohoe K Roethe JL Osborn (2001) ArticleTitleRenal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function Am J Physiol Renal Physiol 281 F887–99 Occurrence Handle1:CAS:528:DC%2BD3MXosFyks7Y%3D Occurrence Handle10.1152/ajprenal.2001.281.5.F887 Occurrence Handle11592947

    Article  CAS  PubMed  Google Scholar 

  74. DP Basile DL Donohoe K Roethe DL Mattson (2003) ArticleTitleChronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage Am J Physiol Renal Physiol 284 F338–48 Occurrence Handle1:CAS:528:DC%2BD3sXhtlOqtb0%3D Occurrence Handle10.1152/ajprenal.00169.2002 Occurrence Handle12388385

    Article  CAS  PubMed  Google Scholar 

  75. KU Eckardt WM Bernhardt A Weidemann C Warnecke C Rosenberger MS Wiesener C Willam (2005) ArticleTitleRole of hypoxia in the pathogenesis of renal disease Kidney Int 99 S46–51 Occurrence Handle1:CAS:528:DC%2BD2MXhtlWqsbfF Occurrence Handle10.1111/j.1523-1755.2005.09909.x

    Article  CAS  Google Scholar 

  76. LG Fine D Bandyopadhay JT Norman (2000) ArticleTitleIs there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia Kidney Int 75 S22–6 Occurrence Handle1:STN:280:DC%2BD3c3ptFagsw%3D%3D Occurrence Handle10.1046/j.1523-1755.2000.07512.x

    Article  CAS  Google Scholar 

  77. DH Kang J Kanellis C Hugo L Truong S Anderson D Kerjaschki et al. (2002) ArticleTitleRole of the microvascular endothelium in progressive renal disease J Am Soc Nephrol 13 806–16 Occurrence Handle10.1097/01.ASN.0000034910.58454.FD Occurrence Handle11856789

    Article  PubMed  Google Scholar 

  78. M Nangaku (2006) ArticleTitleChronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure J Am Soc Nephrol 17 17–25 Occurrence Handle1:CAS:528:DC%2BD28XhtFyqtbY%3D Occurrence Handle10.1681/ASN.2005070757 Occurrence Handle16291837

    Article  CAS  PubMed  Google Scholar 

  79. M Nangaku (2004) ArticleTitleHypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure Nephron Exp Nephrol 98 e8–12 Occurrence Handle10.1159/000079927 Occurrence Handle15361693

    Article  PubMed  Google Scholar 

  80. A Schieppati P Ruggenenti RP Cornejo F Ferrario G Gregorini P Zucchelli et al. (1992) ArticleTitleRenal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic Syndrome J Am Soc Nephrol 2 1640–4 Occurrence Handle1:STN:280:DyaK38zgsFWktw%3D%3D Occurrence Handle1610985

    CAS  PubMed  Google Scholar 

  81. CM Taylor C Chua AJ Howie RA Risdon (2004) ArticleTitleClinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome Pediatr Nephrol 19 419–25 Occurrence Handle1:STN:280:DC%2BD2c7lt1Wmtw%3D%3D Occurrence Handle10.1007/s00467-003-1385-9 Occurrence Handle14986082

    Article  CAS  PubMed  Google Scholar 

  82. AR Constantinescu M Bitzan LS Weiss E Christen BS Kaplan A Cnaan H Trachtman (2004) ArticleTitleNon-enteropathic hemolytic uremic syndrome: causes and short-term course Am J Kidney Dis 43 976–82 Occurrence Handle10.1053/j.ajkd.2004.02.010 Occurrence Handle15168377

    Article  PubMed  Google Scholar 

  83. G Remuzzi P Ruggenenti D Codazzi M Noris J Caprioli G Locatelli B Gridelli (2002) ArticleTitleCombined kidney and liver transplantation for familial haemolytic uraemic syndrome Lancet 359 1671–2 Occurrence Handle10.1016/S0140-6736(02)08560-4 Occurrence Handle12020532

    Article  PubMed  Google Scholar 

  84. G Remuzzi P Ruggenenti B Gridelli A Bertani P Bettinaglio S Bucchioni et al. (2005) ArticleTitleHemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation Am J Transplant 5 1146–50 Occurrence Handle10.1111/j.1600-6143.2005.00783.x Occurrence Handle15816899

    Article  PubMed  Google Scholar 

  85. JM Saland SH Emre BL Shneider C Benchimol S Ames JS Bromberg et al. (2006) ArticleTitleFavorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation Am J Transplant 6 1948–52 Occurrence Handle1:STN:280:DC%2BD28vms1ahsg%3D%3D Occurrence Handle10.1111/j.1600-6143.2006.01375.x Occurrence Handle16889549

    Article  CAS  PubMed  Google Scholar 

  86. GA Rock KH Shumak NA Buskard VS Blanchette JG Kelton RC Nair RA Spasoff (1991) ArticleTitleComparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group N Engl J Med 325 393–7 Occurrence Handle1:STN:280:DyaK3M3oslOnug%3D%3D Occurrence Handle10.1056/NEJM199108083250604 Occurrence Handle2062330

    Article  CAS  PubMed  Google Scholar 

  87. BF Wyllie AX Garg J Macnab GA Rock WF Clark InstitutionalAuthorNameMembers of the Canadian Apheresis Group (2006) ArticleTitleThrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange Br J Haematol 132 204–9 Occurrence Handle1:STN:280:DC%2BD28%2Fht1Oquw%3D%3D Occurrence Handle10.1111/j.1365-2141.2005.05857.x Occurrence Handle16398654

    Article  CAS  PubMed  Google Scholar 

  88. MA Howard LA Williams DR Terrell D Duvall SK Vesely JN George (2006) ArticleTitleComplications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Transfusion 46 154–6 Occurrence Handle10.1111/j.1537-2995.2006.00687.x Occurrence Handle16398746

    Article  PubMed  Google Scholar 

  89. SL Allford BJ Hunt P Rose S Machin (2003) ArticleTitleGuidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias Br J Haematol 120 556–73 Occurrence Handle10.1046/j.1365-2141.2003.04049.x Occurrence Handle12588343

    Article  PubMed  Google Scholar 

  90. JW Smith R Weinstein (2003) ArticleTitleTherapeutic apheresis: a summary of current indication categories endorsed by the AABB and American Society for Apheresis Transfusion 43 820–2 Occurrence Handle10.1046/j.1537-2995.2003.00397.x Occurrence Handle12757535

    Article  PubMed  Google Scholar 

  91. JN George (2006) ArticleTitleClinical practice. Thrombotic thrombocytopenic purpura N Engl J Med 354 1927–35 Occurrence Handle1:CAS:528:DC%2BD28XksVGiurk%3D Occurrence Handle10.1056/NEJMcp053024 Occurrence Handle16672704

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

    Masaomi Nangaku, Hiroshi Nishi & Toshiro Fujita

Authors
  1. Masaomi Nangaku
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Nishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiro Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masaomi Nangaku.

About this article

Cite this article

Nangaku, M., Nishi, H. & Fujita, T. Pathogenesis and prognosis of thrombotic microangiopathy. Clin Exp Nephrol 11, 107–114 (2007). https://doi.org/10.1007/s10157-007-0466-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-007-0466-7

Key words

Search

Navigation